Reviva Pharmaceuticals Stock Forecast - Accumulation Distribution
| RVPH Stock | USD 1.15 0.01 0.88% |
Reviva Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Reviva Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns.
Reviva |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 124717.0 | 45892.83 |
| Check Reviva Pharmaceuticals Volatility | Backtest Reviva Pharmaceuticals | Information Ratio |
Reviva Pharmaceuticals Trading Date Momentum
| On November 25 2024 Reviva Pharmaceuticals Holdings was traded for 1.15 at the closing time. The top price for the day was 1.24 and the lowest listed price was 1.11 . The trading volume for the day was 437.7 K. The trading history from November 25, 2024 did not cause price change. The trading delta at closing time against the current closing price is 1.74% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Reviva Pharmaceuticals to competition |
Other Forecasting Options for Reviva Pharmaceuticals
For every potential investor in Reviva, whether a beginner or expert, Reviva Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Reviva Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Reviva. Basic forecasting techniques help filter out the noise by identifying Reviva Pharmaceuticals' price trends.View Reviva Pharmaceuticals Related Equities
| Risk & Return | Correlation |
Reviva Pharmaceuticals Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Reviva Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Reviva Pharmaceuticals' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Reviva Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Reviva Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Reviva Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Reviva Pharmaceuticals stock market strength indicators, traders can identify Reviva Pharmaceuticals Holdings entry and exit signals to maximize returns.
| Accumulation Distribution | 45892.83 | |||
| Daily Balance Of Power | 0.0769 | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 1.18 | |||
| Day Typical Price | 1.17 | |||
| Price Action Indicator | (0.02) | |||
| Period Momentum Indicator | 0.01 |
Reviva Pharmaceuticals Risk Indicators
The analysis of Reviva Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Reviva Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting reviva stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.89 | |||
| Semi Deviation | 5.88 | |||
| Standard Deviation | 7.03 | |||
| Variance | 49.41 | |||
| Downside Variance | 42.94 | |||
| Semi Variance | 34.52 | |||
| Expected Short fall | (5.63) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Currently Active Assets on Macroaxis
When determining whether Reviva Pharmaceuticals is a strong investment it is important to analyze Reviva Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Reviva Pharmaceuticals' future performance. For an informed investment choice regarding Reviva Stock, refer to the following important reports:Check out Historical Fundamental Analysis of Reviva Pharmaceuticals to cross-verify your projections. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Reviva Pharmaceuticals. If investors know Reviva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Reviva Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.08) | Return On Assets (2.34) | Return On Equity (17.95) |
The market value of Reviva Pharmaceuticals is measured differently than its book value, which is the value of Reviva that is recorded on the company's balance sheet. Investors also form their own opinion of Reviva Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Reviva Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Reviva Pharmaceuticals' market value can be influenced by many factors that don't directly affect Reviva Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Reviva Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Reviva Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Reviva Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.